Next Article in Journal
Asymmetric Intrastromal Corneal Ring Segments with Progressive Base Width and Thickness for Keratoconus: Evaluation of Efficacy and Analysis of Epithelial Remodeling
Previous Article in Journal
Comparison and Evaluation of Outcomes of Ureteroscopy and Stone Laser Fragmentation in Extremes of Age Groups (≤10 Years and ≥80 Years of Age): A Retrospective Comparative Analysis of over 15 Years from 2 Tertiary European Centres
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis

by
Laura Dawn Williams
1 and
Panagiotis Zis
1,2,3,*
1
Medical School, University of Sheffield, Sheffield S10 2RX, UK
2
Medical School, University of Cyprus, Nicosia 2029, Cyprus
3
Second Department of Neurology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 124 62 Athens, Greece
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(4), 1672; https://doi.org/10.3390/jcm12041672
Submission received: 30 November 2022 / Revised: 23 January 2023 / Accepted: 7 February 2023 / Published: 20 February 2023
(This article belongs to the Section Clinical Neurology)

Abstract

Introduction: SARS-CoV-2, responsible for the coronavirus disease (COVID-19) pandemic, may impact other systems apart from the respiratory system, including the nervous system. In this systematic review, we aimed to establish the prevalence and determinants of neuropathic pain amongst COVID-19-infected individuals. Methodology: A literature search in the PubMed database was performed and 11 papers were eligible for inclusion in this systematic review and meta-analysis. Results: The pooled prevalence of COVID-19-related neuropathic pain was 6.7% (95% CI: 4.7–9.5%) for hospitalised patients during the acute phase and 34.3% (95% CI: 14.3–62%) for long COVID patients. The identified risk factors for COVID-19-related neuropathic pain development included depression, COVID-19 severity and azithromycin use. Conclusions: Neuropathic pain is a very common symptom in long COVID, indicating the urgency for further research in this direction.
Keywords: neuropathic pain; COVID-19; long COVID neuropathic pain; COVID-19; long COVID

Share and Cite

MDPI and ACS Style

Williams, L.D.; Zis, P. COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023, 12, 1672. https://doi.org/10.3390/jcm12041672

AMA Style

Williams LD, Zis P. COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2023; 12(4):1672. https://doi.org/10.3390/jcm12041672

Chicago/Turabian Style

Williams, Laura Dawn, and Panagiotis Zis. 2023. "COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 12, no. 4: 1672. https://doi.org/10.3390/jcm12041672

APA Style

Williams, L. D., & Zis, P. (2023). COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(4), 1672. https://doi.org/10.3390/jcm12041672

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop